Alana Harris Dent

Array ( [id] => 16406973 [patent_doc_number] => 10815517 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-27 [patent_title] => Use of DPPIV/seprase as a marker for cancer [patent_app_type] => utility [patent_app_number] => 13/268042 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13673 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13268042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875819 [patent_doc_number] => 08470785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Method for treating ocular cancer' [patent_app_type] => utility [patent_app_number] => 13/246202 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 18333 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13246202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744182 [patent_doc_number] => 20120021946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'METHOD OF DIAGNOSING ESOPHAGEAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/246639 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 48384 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021946.pdf [firstpage_image] =>[orig_patent_app_number] => 13246639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989766 [patent_doc_number] => 20130217047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'KITS FOR DETECTING BREAST OR OVARIAN CANCER IN A BODY FLUID SAMPLE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/825715 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6882 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026361 [patent_doc_number] => 08535942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same' [patent_app_type] => utility [patent_app_number] => 13/242019 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7283 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13242019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393637 [patent_doc_number] => 20120231479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'COMBINATION METHODS OF DIAGNOSING CANCER IN A PATIENT' [patent_app_type] => utility [patent_app_number] => 13/229356 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14088 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13229356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807250 [patent_doc_number] => 20120058204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'USE OF OVER EXPRESSION OF CYSTATHIONINE GAMMA LYASE AS A PROGNOSTIC, DIAGNOSTIC AND THERAPEUTIC TARGET FOR CANCER' [patent_app_type] => utility [patent_app_number] => 13/226730 [patent_app_country] => US [patent_app_date] => 2011-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5903 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058204.pdf [firstpage_image] =>[orig_patent_app_number] => 13226730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9015905 [patent_doc_number] => 20130230869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'ANTIBODY AGAINST COLORECTAL CANCER MARKER' [patent_app_type] => utility [patent_app_number] => 13/820070 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10222 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003647 [patent_doc_number] => 20130224772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'METHOD FOR DETECTING ANTI-HE4 ANTIBODIES AND METHODS OF DIAGNOSIS AND/OR PROGNOSIS OF CONDITIONS ASSOCIATED WITH HE4-EXPRESSING CELLS' [patent_app_type] => utility [patent_app_number] => 13/818466 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10990 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742255 [patent_doc_number] => 20120020960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Thymic Stromal Lymphopoietin (TSLP) and OX40 Ligand in Cancer' [patent_app_type] => utility [patent_app_number] => 13/189244 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 15144 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020960.pdf [firstpage_image] =>[orig_patent_app_number] => 13189244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776278 [patent_doc_number] => 20120039875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'DIAGNOSTIC AND THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING PTEN AND BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/184269 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25213 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039875.pdf [firstpage_image] =>[orig_patent_app_number] => 13184269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094165 [patent_doc_number] => 20120082689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Method of treatment an oncological disease' [patent_app_type] => utility [patent_app_number] => 13/135693 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3447 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082689.pdf [firstpage_image] =>[orig_patent_app_number] => 13135693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927545 [patent_doc_number] => 20130183305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO' [patent_app_type] => utility [patent_app_number] => 13/808423 [patent_app_country] => US [patent_app_date] => 2011-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25459 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586366 [patent_doc_number] => 20110280876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'MUTATED NETRIN - 4, FRAGMENTS THEREOF AND THEIR USE AS MEDICINES' [patent_app_type] => utility [patent_app_number] => 13/171756 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 37629 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280876.pdf [firstpage_image] =>[orig_patent_app_number] => 13171756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656438 [patent_doc_number] => 20110305707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/160941 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 17266 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305707.pdf [firstpage_image] =>[orig_patent_app_number] => 13160941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9435403 [patent_doc_number] => 20140113310 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2014-04-24 [patent_title] => 'CANCER DETECTION MARKERS' [patent_app_type] => utility [patent_app_number] => 13/154143 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12217 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9435403 [patent_doc_number] => 20140113310 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2014-04-24 [patent_title] => 'CANCER DETECTION MARKERS' [patent_app_type] => utility [patent_app_number] => 13/154143 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12217 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696606 [patent_doc_number] => 20110229984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'MATERIALS AND METHODS DIRECTED TO ASPARAGINE SYNTHETASE AND ASPARAGINASE THERAPIES' [patent_app_type] => utility [patent_app_number] => 13/151420 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23740 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229984.pdf [firstpage_image] =>[orig_patent_app_number] => 13151420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9121318 [patent_doc_number] => 20130288240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'ALK AND ROS KINASE IN CANCER' [patent_app_type] => utility [patent_app_number] => 13/699309 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 31605 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10077559 [patent_doc_number] => 09115402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Compositions and methods of identifying tumor specific neoantigens' [patent_app_type] => utility [patent_app_number] => 13/108610 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 24 [patent_no_of_words] => 23801 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 516 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13108610 [rel_patent_id] =>[rel_patent_doc_number] =>)